Kian Sadeghi
Showing 1–2 of 2 transcripts.
Nucleus Launches First Genetically Optimized Embryo
Nucleus Embryo, led by founder Keon, has launched a genetic optimization platform in partnership with Genomic Prediction that enables parents to analyze IVF embryos for traits ranging from disease risks to cognitive potential. The technology addresses the rising adoption of IVF by offering a full-stack solution for generational health, differentiating itself from standard clinical screenings through direct-to-consumer access to comprehensive genomic data. While acknowledging that the system provides relative optimization rather than the creation of specific individuals, the company aims to democratize access to this preventative care technology to reduce the prevalence of genetic disorders.
The Quiet Revolution in DNA Sequencing | Nucleus Genomics
Nucleus Genomics, backed by investors including Alexis Ohanian and Peter Thiel's Founders Fund, has launched its $399 whole-genome sequencing service to build a trillion-dollar consumer healthcare platform that integrates genetic data with wearable and clinical inputs. Led by Kian Sadegi, the company differentiates itself from competitors by utilizing full genome sequencing rather than SNP-based chips to offer features like the Nucleus IQ polygenic score while maintaining strict data privacy controls. With a roadmap to sequence 500,000 samples within two years, Nucleus aims to disrupt the stagnant genomics market by providing direct consumer access to comprehensive health insights and expanding disease analysis from twenty to hundreds of conditions.